294 related articles for article (PubMed ID: 31920171)
1. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
2. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
3. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
6. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
7. [The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].
Kaya H; Karkucak M; Salifoğlu H; Torun D; Kozan S; Tunca Y
Tuberk Toraks; 2013; 61(2):88-95. PubMed ID: 23875585
[TBL] [Abstract][Full Text] [Related]
8. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
Ringelstein M; Jung A; Berger K; Stoll M; Madlener K; Klötzsch C; Schlachetzki F; Stolz E
J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
[TBL] [Abstract][Full Text] [Related]
9. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of plasminogen activator inhibitor-1 promoter 4G/5G polymorphism in breast cancer: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
Arch Med Res; 2013 Jan; 44(1):39-45. PubMed ID: 23291383
[TBL] [Abstract][Full Text] [Related]
11. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.
Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Miletich JP
Circulation; 1997 Jan; 95(1):59-62. PubMed ID: 8994417
[TBL] [Abstract][Full Text] [Related]
12. Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients.
Wang B; Xu P; Shu Q; Yan S; Xu H
Clin Appl Thromb Hemost; 2021; 27():10760296211031291. PubMed ID: 34325549
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
[TBL] [Abstract][Full Text] [Related]
14. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
[TBL] [Abstract][Full Text] [Related]
15. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
[TBL] [Abstract][Full Text] [Related]
17. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
Zhang X; Gao B; Xu B
Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
[TBL] [Abstract][Full Text] [Related]
18. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
[TBL] [Abstract][Full Text] [Related]
19. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
Yıldırım ME; Karakuş S; Kurtulgan HK; Kılıçgün H; Erşan S; Bakır S
Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
[TBL] [Abstract][Full Text] [Related]
20. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]